Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer

E-ISSN： 1873-5592|10|6|575-576

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.6, 2009-06, pp. : 575-576

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes

By Prada Patricia O

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 751-763

Informa Healthcare

Access to resources Recommend Favorite

Protein tyrosine kinase inhibitors in cancer treatment

By Traxler P.M.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. : 571-588

Informa Healthcare

Access to resources Recommend Favorite

Tyrosine kinase inhibitors in cancer treatment (Part II)

By Traxler P.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. : 1599-1625

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer

By Zámečníkova Adriana

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 77-92

Informa Healthcare

Access to resources Recommend Favorite

Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 175-185

Bentham Science Publishers

Access to resources Recommend Favorite